The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemis liver injury in the rat

Hepatology

Volumn 26, Issue 5, 1997, Pages 1182-1188

  Leclercq, Isabelle ^a   Saliez, Alain ^a   Wallemacq, Pierre E ^a   Horsmans, Yves ^a   Lambotte, Luc ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEETHYLLIDOCAINE; DRUG METABOLITE; LIDOCAINE; LIVER ENZYME; LOCAL ANESTHETIC AGENT;

ANIMAL MODEL; ARTICLE; CHRONIC LIVER DISEASE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER ISCHEMIA; LIVER METABOLISM; LIVER MICROSOME; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030663534     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260515     Document Type: Article

References (33)

1. Potter JM, Oellerich M. The use of lidocaine as a test of liver function in liver transplantation. Liver Transplant Surg 1996; 2:211-224.
2. von Bahr C, Hedlund I, Karlen B, Backstrom D, Grasdalen H. Evidence for two catalytically different binding sites of liver microsomal cytochrome P-450: importance for species and sex differences in oxidation pattern of lidocaine. Acta Pharmacol et Toxicol 1977; 41:39-48.
3. Stenson RE, Constantino RT, Harrison DC. Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation 1971; 43:205-211.
4. Oellerich M, Raude E, Burdelski M, Schulz M, Schmidt FW, Ringe B, Lamesch P, et al. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987; 25:845-853.
5. Huang YS, Lee SD, Deng JF, Wu JC, Lu RH, Lin YF, Wang YJ, et al. Measuring lidocaine metabolite - monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol 1993; 19:140-147.
6. Arrigoni A, Gindro T, Aimo G, Cappello N, Meloni A, Benedetti P, Molino GP, et al. Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. HEPATOLOGY 1994; 20:383-387.
7. Oellerich M, Burdelski M, Ringe B, Wittekind C, Lamesch P, Lautz HU, Gaubernatis G, et al. Functional state of the donor liver and early outcome of transplantation. Transplant Proc 1991; 23:1575-1578.
8. Ghent CN, Wall WJ. The lidocaine monoethylglycinexylidide test of liver function. J Pharmacol Exp Ther 1996; 180:454-463.
9. Oellerich M, Burdelski M, Lautz HU, Schulz M, Schmidt FW, Herrmann H. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther Drug Monit 1990; 12:219-226.
10. Gremse DA, A-Kader HH, Schroeder TJ, Balistreri WF. Assessment of lidocaine metabolite formation as a quantitative liver function test in children. HEPATOLOGY 1990; 12:565-569.
11. Michell ID, Abdulnour I, Pzybylowski G, Bowkett J, Gleeson A, Hardy KJ, Jones RM, et al. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function. Transplant Proc 1993; 25:2888-2889.
12. Fairchild R, Solomon H, Conti J, Kaminski D. Prognostic value of the monoethylglycinexilidide liver function test in assessing donor liver suitability. Arch Surg 1996; 131:1099-1102.
13. Reding R, Wallemacq P, de Ville de Goyet J, Lerut J, Hausleithner V, Feyaerts A, Lambotte L, et al. The unreliability of the lidocaine/ monoethylglycinexylidide test for assessment of liver donors. Transplantation 1993; 56:323-326.
14. Hausleithner V, de Ville de Goyet J, Wallemacq P, Lambotte L. Study of the monoethylglycinexylidide (MEGX)-test in rats. J Hepatol 1992; 16:S95.
15. Imaoka S, Enomoto K, Oda Y, et al. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s. J Pharmacol Exp Ther 1990; 255:1385-1391.
16. Hermansson J, Glauann H, Karlen B, von Bahr C. Metabolism of lidocaine in human liver in vitro. Acta Pharmacol Toxicol 1980; 47:49-52.
17. Kawai R, Fujita S, Suzuki T. A new lidocaine metabolite, w-diethylamino-2-hydroxymethyl-6-methylacetanilide. Drug Metab Dispos 1986; 14:277-279.
18. Alvarez-Lopez A, de Hemptinne B, Hoebeke Y, Lambotte L. Prostaglandin E2 increases the tolerance of the rat liver to warm ischemia in absence of splanchnic congestion. Transplant Proc 1987; 19:4105-4109.
19. Guengerich FP. Preparation and properties of highly purified cytochrome P-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. Mol Pharmacol 1977; 13:911-923.
20. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
21. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. II: Solubilization, purification and properties. J Biol Chem 1964; 239:2370-2385.
22. Horsmans Y, Stevens M, Geubel A, Harvengt C, Rahier J. Immunoquantification of cytochrome P-450 3A on rat paraffin embedded liver tissue. Liver 1992; 12:344-350.
23. Motassim N, Decolin D, Le Dinh T, Nicolas A, Siest G. Direct determination of dextromethorphan and its three metabolites in urine by high-performance liquid chromatography using a precolumn switching system for sample clean-up. J Chrom 1987; 422:340-345.
24. Kawai R, Fujita S, Suzuki T. Simultaneous quantitation of lidocaine and its four metabolites by high-performance liquid chromatography: application to studies on in vitro and in vivo metabolism of lidocaine in rats. J Pharm Sci 1985; 74:1219-1224.
25. Meyer Wyss B, Renner E, Luo H, Scholer A. Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. J Hepatol 1993; 19:133-139.
26. Karayalcin K, Mirza DF, Harrison RF, Da Silva RF, Hubscher SJ, Mayer AD, Buckels JA, et al. The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 1994; 24:1323-1327.
27. Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 1989; 46:521-527.
28. Oda Y, Imaoka S, Nakahira Y, Asada A, Fujimori M, Fujita S, Funae Y. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes. Biochem Pharmacol 1989; 38:4439-4444.
29. Izuishi K, Hamamoto I, Ichikawa Y, Okano K, Akram HM, Maeba T, Tanaka S. Effect of warm ischemia on the hepatic microsomal cytochrome P-450 monooxygenase system. Transplant Proc 1994; 26:2417-2419.
30. Suzuki T, Fujita S, Kawai R. Precursor-metabolite interaction in the metabolism of lidocaine. J Pharm Sci 1984; 73:136-138.
31. Saville BA, Gray MR, Tam YK. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. Drug Metab Dispos 1987; 15:17-21.
32. Bowers BA, Branum GD, Rotolo FS, Watters CR, Meyers WC. Bile flow - An index of ischemic injury. J Surg Res 1987; 42:565-569.
33. Karwinski W, Husoy AM, Farstad M, Soreide O. Sixty minutes of normothermic ischemia in the rat liver: correlation between adenine nucleotides and bile excretion. J Surg Res 1989; 46:99-103.